, Tracking Stock Market Picks
Enter Symbol:
LyondellBasell Industries NV (LYB) [hlAlert]

down 23.63 %

LyondellBasell Industries NV (LYB) rated Buy by Standpoint Research

Posted on: Friday,  May 8, 2015  9:25 AM ET by Standpoint Research

Standpoint Research rated Buy LyondellBasell Industries NV (NYSE: LYB) on 05/08/2015, when the stock price was $105.94. Since
then, LyondellBasell Industries NV has lost 23.64% as of 01/26/2016's recent price of $80.90.
If you would have followed this Standpoint Research's recommendation on LYB, you would have lost 23.63% of your investment in 263 days.

LyondellBasell Industries NV is a Netherlands-based company engaged in the chemical industry. The Company products are divided into four sections: Olefins and Polyefins, Intermediates and Derivatives,Refining and Oxyfuels and Technology. It produces polypropylene and polypropylene compounds, propylene oxide, polyethylene, ethylene and propylene. It is also a producer of refined products, including biofuels. The products are used in such industries as packaging, electronics, automotive components, home furnishings, construction materials and biofuels. The Company has production unites in the United States, South America, Europe, Asia and the Middle East. Its regional sales offices are located in Netherlands, Honk Kong, China, Indian and the United Arab Emirates with a worldwide network of local sales and representative offices in Europe, Asia and Africa.

Standpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive track record of recommendations.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/8/2015 9:25 AM Buy
as of 8/27/2015
1 Week up  0.45 %
1 Month down  -19.30 %
3 Months down  -19.11 %
1 YTD down  -20.43 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy